Please login to the form below

Not currently logged in
Email:
Password:

Stephen Whitehead appointed as ABPI CEO

Stephen Whitehead will take up the role of ABPI CEO with effect from June 1, taking over from Richard Barker who steps down as director general on May 25

The Association of the British Pharmaceutical Industry (ABPI) has announced Stephen Whitehead will take up the role of CEO with effect from June 1, taking over from Richard Barker who steps down as director general on May 25.

ABPI president Simon Jose said: "The Board of Management is delighted by this appointment. We are in a time of dynamic change for the health service, the economy, our industry and the ABPI itself. As chief executive, Stephen brings skills and experiences that will enable us to meet the challenges ahead with energy and creativity."

It will be essential to work collaboratively and flexibly to realise the value of medicines in contributing to patients' well-being and to promote the vital importance of this industry in the UK

Whitehead joins the ABPI from Prudential PLC where he held the role of group communications director. He has previously held senior leadership roles at Barclays PLC and Allied Domecq PLC.

Earlier in his career, Whitehead spent ten years at GlaxoSmithKline (GSK) and Eli Lilly at UK, European and international level. 

Whitehead has considerable experience working in regulated industries, has led significant change and modernisation programmes and has extensive experience of developing high performing teams. 

Commenting on his appointment, Whitehead said: "In today's changing environment and demanding economic circumstances it will be essential to work collaboratively and flexibly to realise the value of medicines in contributing to patients' well-being and to promote the vital importance of this industry in the UK, a traditional home of discovery, innovation and research and development."

5th April 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Article
How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Podcast
Living With Chronic Illness (Series one)...

Infographics